4th Quarter - Report

CAPITOL HILL STRATEGIES, LLC for MERCK & CO., INC

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1548, Pathway for Biosimilars Act of 2009 H.R. 1427, Promoting Innovation and Access to Life-saving Medicines Act H.R. 2502, Comparative Effectiveness Research Act of 2009 S. 1213, Patient-Centered Outcomes Research Act of 2009 H.R. 3590, the Patient Protection and Affordable Care Act of 2009 (Comparative Effectiveness Research, Vaccine, Follow on Biologics)

LobbyistCovered position, as disclosed
PAUL S BOCK New Chief of Staff, Sen. Kohl
CHARLES M BRAIN Asst. to the President, Dp.Chief Staff W&M Cmte
BEAU` SCHUYLER LD-CongTanner, LD-CongMcIntyre,SA-CongRose
A. J. WOJCIAK Senior Legislative Asst., Cong. Earl Pomeroy

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2502 (111th), H.R. 1548 (111th), H.R. 3590 (111th), H.R. 1427 (111th), S. 1213 (111th)

Medicare/Medicaid MMM

S. 1679, the Affordable Health Choices Act (Comparative Effectiveness Research, Part D provisions, 340B provisions, Follow on biologics) H.R. 3962, America's Affordable Health Choices Act of 2009 (Comparative Effectiveness Research, Part D provisions, 340B provisions, Follow on Biologics )

LobbyistCovered position, as disclosed
PAUL S BOCK New Chief of Staff, Sen. Kohl
CHARLES M BRAIN Asst. to the President,Dp.Chief Staff W&MCmte.
BEAU` SCHUYLER LD-CongTanner,LD-CongMcIntyre,SA-CongRose
A. J. WOJCIAK Senior Legislative Asst., Cong. Earl Pomeroy

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3962 (111th), S. 1679 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.